171 related articles for article (PubMed ID: 14630694)
21. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations.
Drexler HG; Quentmeier H; MacLeod RA
Leukemia; 2004 Feb; 18(2):227-32. PubMed ID: 14671638
[TBL] [Abstract][Full Text] [Related]
22. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).
Domer PH; Head DR; Renganathan N; Raimondi SC; Yang E; Atlas M
Leukemia; 1995 Aug; 9(8):1305-12. PubMed ID: 7643617
[TBL] [Abstract][Full Text] [Related]
23. Targeted down-regulation of MLL-AF9 with antisense oligodeoxyribonucleotide reduces the expression of the HOXA7 and -A10 genes and induces apoptosis in a human leukemia cell line, THP-1.
Kawagoe H; Kawagoe R; Sano K
Leukemia; 2001 Nov; 15(11):1743-9. PubMed ID: 11681416
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins.
Ayton PM; Cleary ML
Oncogene; 2001 Sep; 20(40):5695-707. PubMed ID: 11607819
[TBL] [Abstract][Full Text] [Related]
25. Leukemias related to treatment with DNA topoisomerase II inhibitors.
Felix CA
Med Pediatr Oncol; 2001 May; 36(5):525-35. PubMed ID: 11340607
[TBL] [Abstract][Full Text] [Related]
26. Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias.
Megonigal MD; Rappaport EF; Jones DH; Kim CS; Nowell PC; Lange BJ; Felix CA
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11583-8. PubMed ID: 9326653
[TBL] [Abstract][Full Text] [Related]
27. Human LPP gene is fused to MLL in a secondary acute leukemia with a t(3;11) (q28;q23).
Dahéron L; Veinstein A; Brizard F; Drabkin H; Lacotte L; Guilhot F; Larsen CJ; Brizard A; Roche J
Genes Chromosomes Cancer; 2001 Aug; 31(4):382-9. PubMed ID: 11433529
[TBL] [Abstract][Full Text] [Related]
28. The small oligomerization domain of gephyrin converts MLL to an oncogene.
Eguchi M; Eguchi-Ishimae M; Greaves M
Blood; 2004 May; 103(10):3876-82. PubMed ID: 14751928
[TBL] [Abstract][Full Text] [Related]
29. Secondary leukemias induced by topoisomerase-targeted drugs.
Felix CA
Biochim Biophys Acta; 1998 Oct; 1400(1-3):233-55. PubMed ID: 9748598
[TBL] [Abstract][Full Text] [Related]
30. Etoposide and illegitimate DNA double-strand break repair in the generation of MLL translocations: new insights and new questions.
Sung PA; Libura J; Richardson C
DNA Repair (Amst); 2006 Sep; 5(9-10):1109-18. PubMed ID: 16809075
[TBL] [Abstract][Full Text] [Related]
31. Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias.
Cimino G; Rapanotti MC; Biondi A; Elia L; Lo Coco F; Price C; Rossi V; Rivolta A; Canaani E; Croce CM; Mandelli F; Greaves M
Cancer Res; 1997 Jul; 57(14):2879-83. PubMed ID: 9230194
[TBL] [Abstract][Full Text] [Related]
32. Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia.
Blanco JG; Dervieux T; Edick MJ; Mehta PK; Rubnitz JE; Shurtleff S; Raimondi SC; Behm FG; Pui CH; Relling MV
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10338-43. PubMed ID: 11526240
[TBL] [Abstract][Full Text] [Related]
33. Structure of AF3p21, a new member of mixed lineage leukemia (MLL) fusion partner proteins-implication for MLL-induced leukemogenesis.
Sano K
Leuk Lymphoma; 2001 Aug; 42(4):595-602. PubMed ID: 11697487
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic tool for the identification of MLL rearrangements including unknown partner genes.
Meyer C; Schneider B; Reichel M; Angermueller S; Strehl S; Schnittger S; Schoch C; Jansen MW; van Dongen JJ; Pieters R; Haas OA; Dingermann T; Klingebiel T; Marschalek R
Proc Natl Acad Sci U S A; 2005 Jan; 102(2):449-54. PubMed ID: 15626757
[TBL] [Abstract][Full Text] [Related]
35. Molecular analysis of the rearranged genome and chimeric mRNAs caused by the t(6;11)(q27;q23) chromosome translocation involving MLL in an infant acute monocytic leukemia.
Akao Y; Isobe M
Genes Chromosomes Cancer; 2000 Apr; 27(4):412-7. PubMed ID: 10719372
[TBL] [Abstract][Full Text] [Related]
36. Characterization of genomic breakpoints in MLL and CBP in leukemia patients with t(11;16).
Zhang Y; Zeleznik-Le N; Emmanuel N; Jayathilaka N; Chen J; Strissel P; Strick R; Li L; Neilly MB; Taki T; Hayashi Y; Kaneko Y; Schlegelberger B; Rowley JD
Genes Chromosomes Cancer; 2004 Nov; 41(3):257-65. PubMed ID: 15334549
[TBL] [Abstract][Full Text] [Related]
37. AF4p12, a human homologue to the furry gene of Drosophila, as a novel MLL fusion partner.
Hayette S; Cornillet-Lefebvre P; Tigaud I; Struski S; Forissier S; Berchet A; Doll D; Gillot L; Brahim W; Delabesse E; Magaud JP; Rimokh R
Cancer Res; 2005 Aug; 65(15):6521-5. PubMed ID: 16061630
[TBL] [Abstract][Full Text] [Related]
38. LDI-PCR: identification of known and unknown gene fusions of the human MLL gene.
Meyer C; Marschalek R
Methods Mol Biol; 2009; 538():71-83. PubMed ID: 19277576
[TBL] [Abstract][Full Text] [Related]
39. Cryptic splice site activation during RNA processing of MLL/AF4 chimeric transcripts in infants with t(4;11) positive ALL.
Divoky V; Trka JM; Watzinger F; Lion T
Gene; 2000 Apr; 247(1-2):111-8. PubMed ID: 10773450
[TBL] [Abstract][Full Text] [Related]
40. MLL/GRAF fusion in an infant acute monocytic leukemia (AML M5b) with a cytogenetically cryptic ins(5;11)(q31;q23q23).
Panagopoulos I; Kitagawa A; Isaksson M; Mörse H; Mitelman F; Johansson B
Genes Chromosomes Cancer; 2004 Dec; 41(4):400-4. PubMed ID: 15382263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
